Drug Shortage Report for SANDOZ RISPERIDONE
Report ID | 146330 |
Drug Identification Number | 02279827 |
Brand name | SANDOZ RISPERIDONE |
Common or Proper name | RISPERIDONE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | RISPERIDONE |
Strength(s) | 3.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100FCT BO |
ATC code | N05AX |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2021-09-27 |
Estimated end date | 2021-10-08 |
Actual end date | 2021-10-15 |
Shortage status | Resolved |
Updated date | 2021-10-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2021-10-16 | English | Compare |
v4 | 2021-10-15 | French | Compare |
v3 | 2021-10-15 | English | Compare |
v2 | 2021-09-28 | French | Compare |
v1 | 2021-09-28 | English | Compare |
Showing 1 to 5 of 5